130 related articles for article (PubMed ID: 9495704)
1. Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up.
Miller MI; Puchner PJ
Urology; 1998 Feb; 51(2):237-40. PubMed ID: 9495704
[TBL] [Abstract][Full Text] [Related]
2. The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report.
Puchner PJ; Miller MI
J Urol; 1995 Nov; 154(5):1779-82. PubMed ID: 7563345
[TBL] [Abstract][Full Text] [Related]
3. Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia.
Kearney MC; Bingham J; Bergland R; Meade-D'Alisera P; Puchner PJ
J Urol; 2002 Jun; 167(6):2489-91. PubMed ID: 11992064
[TBL] [Abstract][Full Text] [Related]
4. Role of finasteride in the treatment of recurrent hematuria secondary to benign prostatic hyperplasia.
Carlin BI; Bodner DR; Spirnak JP; Resnick MI
Prostate; 1997 May; 31(3):180-2. PubMed ID: 9167770
[TBL] [Abstract][Full Text] [Related]
5. Finasteride: a long-term follow-up in the treatment of recurrent hematuria associated with benign prostatic hyperplasia.
Delakas D; Lianos E; Karyotis I; Cranidis A
Urol Int; 2001; 67(1):69-72. PubMed ID: 11464120
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride.
Foley SJ; Soloman LZ; Wedderburn AW; Kashif KM; Summerton D; Basketter V; Holmes SA
J Urol; 2000 Feb; 163(2):496-8. PubMed ID: 10647664
[TBL] [Abstract][Full Text] [Related]
7. Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia.
Memis A; Ozden C; Ozdal OL; Guzel O; Han O; Seckin S
Urol Int; 2008; 80(2):177-80. PubMed ID: 18362489
[TBL] [Abstract][Full Text] [Related]
8. [Finasteride: an effective therapeutic for benign prostatic hyperplasia related gross hematuria in patients receiving anticoagulant].
Lin YH; Jiang YG; Li MC; Peng T
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):31-3. PubMed ID: 19288745
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
Palou Redorta J; Gausa Gascon L; Salvador Bayarre J; Millán Rodríguez F; Segarra Tomás J; Villavicencio Mavrich H
Arch Esp Urol; 2002 Oct; 55(8):895-9. PubMed ID: 12455279
[TBL] [Abstract][Full Text] [Related]
10. Re: A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride.
Harrison RH
J Urol; 2000 Nov; 164(5):1670-1. PubMed ID: 11203073
[No Abstract] [Full Text] [Related]
11. The treatment of gross hematuria secondary to prostatic bleeding with finasteride.
Sieber PR; Rommel FM; Huffnagle HW; Breslin JA; Agusta VE; Harpster LE
J Urol; 1998 Apr; 159(4):1232-3. PubMed ID: 9507842
[TBL] [Abstract][Full Text] [Related]
12. [Effects of finasteride on hematuria associated with benign prostatic hyperplasia: a meta-analysis].
Jiang Y; Long YF
Zhonghua Nan Ke Xue; 2010 Aug; 16(8):726-9. PubMed ID: 21090349
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with finasteride in men with symptomatic benign prostatic hyperplasia: 10-year follow-up.
Lam JS; Romas NA; Lowe FC
Urology; 2003 Feb; 61(2):354-8. PubMed ID: 12597947
[TBL] [Abstract][Full Text] [Related]
14. Effects of finasteride and cyproterone acetate on hematuria associated with benign prostatic hyperplasia: a prospective, randomized, controlled study.
Perimenis P; Gyftopoulos K; Markou S; Barbalias G
Urology; 2002 Mar; 59(3):373-7. PubMed ID: 11880073
[TBL] [Abstract][Full Text] [Related]
15. Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia.
Hochberg DA; Basillote JB; Armenakas NA; Vasovic L; Shevchuk M; Pareek G; Fracchia JA
J Urol; 2002 Apr; 167(4):1731-3. PubMed ID: 11912398
[TBL] [Abstract][Full Text] [Related]
16. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
[TBL] [Abstract][Full Text] [Related]
17. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
Lepor H; Williford WO; Barry MJ; Haakenson C; Jones K
J Urol; 1998 Oct; 160(4):1358-67. PubMed ID: 9751354
[TBL] [Abstract][Full Text] [Related]
18. Patient satisfaction with finasteride in the treatment of symptomatic benign prostatic hyperplasia.
Kaplan SA; Olsson CA
Clin Ther; 1996; 18(1):73-83. PubMed ID: 8851454
[TBL] [Abstract][Full Text] [Related]
19. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
Agha AH; Roy JB; Culkin DJ; Lyon K
Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
[TBL] [Abstract][Full Text] [Related]
20. Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
Roehrborn CG; Bruskewitz R; Nickel JC; McConnell JD; Saltzman B; Gittelman MC; Malek GH; Gottesman JE; Suryawanshi S; Drisko J; Meehan A; Waldstreicher J;
J Urol; 2004 Mar; 171(3):1194-8. PubMed ID: 14767299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
